Abstract:
NEW QUINOXALINE-DI - N - OXIDE-LACTONES HAVING ANTIFUNGAL ACTIVITY ARE PROVIDED WHICH ARE PREPARED FROM A 2 - ACYLOXY-METHYL-3-CARBOXAMIDO-QUINOXALINE - DI - NOXIDE-(1,4) STARTING MATERIAL BY REACTION WITH AN INORGANIC OR ORGANIC ACID AT A TEMPERATURE OF 0* TO 100*C. IN A DILUENT.
R IS ALKYL WITH 1 TO 12 CARBON ATOMS, PREFERABLY ALKYL WITH 1 TO 4 CARBON ATOMS SUCH AS METHYL OR TERTIARY BUTYL; R2 IS ALKYL WITH 1 TO 8 CARBON ATOMS; THE -OH GROUP IS IN THE 2 OR 4 POSITION; N IS AN INTEGER FROM 0 TO 12, PREFERABLY 3 OR 2; R'' IS HYDROGEN OR ALKYL WITH 1 TO 4 CARBON ATOMS AND PREFERABLY METHYL; AND X IS A DEVALENT INORGANIC RADICAL, PREFERABLY>N-NH2, -O-, OR >SO2. SUCH COMPOUNDS ARE USEFUL TO STABILIZE ISOCYANATES AGAINST DISCOLORATION DURING STORAGE.
Abstract:
QUINOXALINE-DI-N-OXIDES, HAVING PHARMACOLOGICAL PROPERTIES AND USABLE AS INTERMEDIATES FOR PRODUCTING PLANT PROTECTING AGENTS, PRODUCED BY REACTING IN AN ORGANIC DILUENT (E.G. AT 20-100*C.) BENZOFURAZANE-N-OXIDE (OPTIONALLY SUBSTITUTED WITH HALO, ALKYL, ALKOXY, ACYL, SUBSTITUTED ACYL, AMIDO, SUBSTITUTED AMIDO, SULFONAMIDO, AND/ OR SUBSTITUTED SULFONAMIDO)WITH A REAGENT COMPOSED OF EITHER (A) AT LEAST AN EQUIVALENT QUANTITY OF BOTH AN ORGANIC CARBONYL COMPOUND (E.G. LINERR OR CYLCLO ALIPHATIC, ARYL, OR HETEROCYCLIC CARBONYL COMPOUND) WITH IS OPTIONALLY SUBSTITUTED AND WHICH CONTAINS THE LINKAGE
-CH2-CO-
AND A PRIMARY ALIPHATIC AMINE OR AMMONIA; OR (B) AT LEAST AN EQUIVALENT QUANTITY OF THE CORRESPONDING SCHIFF''S BASE TO THE REAGENT UNDER (A).
Abstract:
2-METHYL-3-CARBOXYLIC ACID-AMIDO-QUINOXALINE - 1,4-DIN-OXIDES OF THE FORMULA:
1,4-DI(O=),2-CH3,3-(R2-N(-R3)-OC-),R1-QUINOXALINE
WHEREIN: R1 IS HYDROGEN, LOWER ALKYL, LOWER ALKOXY OR CHLORINE, R2 IS HYDROGEN, STRAIGHT OR BRANCHED CHAIN ALKYL OR STRAIGHT OR BRANCHED CHAIN ALKYL SUBSTITUTED BY HYDROXY, LOWER ALKOXY, CARBALKOXY, MONOALKYLAMINO OR DIALKYLAMINO, AND R3 IS HYDROGEN, STRAIGHT OR BRANCHED CHAIN ALKYL, STRAIGHT OR BRANCHED CHAIN ALKYL SUBSTITUTED BY HYDROXY, LOWER ALKOXY, CARBALKOXY, MONOALKYLAMINO OR DIALKYLAMINO, OR WHEN R2 IS IS HYDROGEN, CYCLOHEXYL, OR R2 AND R3 TOGETHER WITH THE AMIDE NITROGEN ATOM FORM PART OF A 5OR 6-MEMBERED HETEROCYCLIC RING, ARE USEFUL FOR THEIR ANTIBACTERIAL EFFECT. THESE COMPOUNDS MAY BE PRODUCED, INTER ALIA, BY REACTING A BENZOFUROXAN OF THE FORMULA:
WHEREIN: R1 IS HYDROGEN, LOWER ALKYL, LOWER ALKOXYL, HYDROXY OR AN ACLOXY MOIETY OF A LOWER ALIPHATIC CARBOXYLIC ACID AND WHEREIN R1 IS FROM 1 TO 5 SUCH MOIETIES, R2 IS HYDROGEN, AND ALIPHATIC MOIETY OR AN ALIPHATIC MOIETY SUBSTITUTED BY HYDROXY, LOWER ALKOXY, CARBALKOXY, MONOALKYLAMINO OR DIALKYLAMINO, R3 IS HYDROGEN AND ALIPHATIC MOIETY OR LAN ALIPHATIC MOIETY SUBSTITUTED BY HYDROXYL, LOWR ALKOXY, CARBALKOXY, MONOALKYLAMINO OR DIALKYLAMINO, OR R2 AND R3 ARE EACH LOWER ALKYL LINKED TOGETHER WITH THE AMIDE NITROGEN TO FROM A 5-,6- OR 7-MEMBERED HETEROCYCLIC RING OR R2 AND R3 ARE EACH LOWER ALKYL LINKED TOGETHER WITH AN AMIDE NITROGEN TO FORM A 5-, 6- RO 7-MEMBERED HETEROCYCLIC RING HAVING N OR O AS A SECOND HETEROATOM, AND R4 IS HYDROGEN, LOWER ALKYL OR SUBSITURED OR UNSUBSTITUTED PHENYL, ARE USEFUL FOR THEIR ANTIBACTERIAL ACITVITY.
Abstract:
Pharmaceutical compositions are provided for controlling bacterial infections caused by gram-positive and gram-negative bacteria containing a 3-carboxylic acid amido-quinoxaline-1,4-diN-oxide as active ingredient, as exemplified by 2-acetoxymethyl3-carboxylic acid ethylamidoquinoxaline-di-N-oxide and its congeners. The dosage ranges from 5 mg/kg to 150 mg/kg daily orally or parenterally.
Abstract:
COMPOUNDS, AND COMPOSITIONS CONTAINING THEM, ARE PROVIDED FOR CONTROLLING BACTERIAL INFECTIONS CAUSED BY GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA. THE COMPOUNDS ARE 3-CARBOXYLIC ACID AMIDO-QUINOXALINE-1,4-DI-N-OXIDES EXEMPLIED BY 2-ACETOXYMETHYL-3-CARBOXYLIC ACID ETHYLAMIDOQUINOXALINE-DI-N-OXIDE AND ITS CONGENERS PREPARED BY REACTING A 2-HALOMETHYL-3-CARBOXYLIC ACID AMIDO-QUINOXALINE,1,4-DI-N-OXIDE, WHEREIN HALO IS CHLORO OR BROMO, WITH A MONOCARBOXYLIC ACID ALKALI SALT IN AN ORGANIC SOLVENT WITH OR WITHOUT WATER PRESENT AT 40-160*C. THE SALT IS OF THE TYPE
ALKYL-CO-X-M OR PHENYL-CO-X-M
WHERE X IS S OR O AND M IS NA, K OR NH4. THE ALKYL GROUP CAN BE HALOGENATED AND THE PHENYL GROUP CAN BE SUBSTITUTED BY HYDROXY, METHYOXY OR ACETOXY. THE DOSAGE RANGES FROM 5 MG./KG. TO 150 MG./KG. DAILY ORALLY OR PARENTERALLY.
WHEREIN: R1 IS HYDROGEN, LOWER ALKYL, LOWER ALKOXY OR CHLORINE, R2 IS HYDROGEN, STRAIGHT OR BRANCHED CHAIN ALKYL OR STRAIGHT OR BRANCHED CHAIN ALKYL SUBSTITUTED BY HYDROXY, LOWER ALKOXY, ACYLOXY, MONOALKYLAMINO OR DIALKYLAMINO, R3 IS HYDROGEN, STRAIGHT OR BRANCHED CHAIN ALKYL, STRAIGHT OR BRANCHED CHAIN ALKYL SUBSTITUTED BY HYDROXY, LOWER ALKOXY, ACYLOXY, MONALKYLAMINO OR DIALKYLAMINO, OR WHEN R2 IS HYDROGEN, CYCLOHEXYL, OR R2 AND R3 TOGETHER WITH THE AMIDE NITROGEN ATOM FORM PART OF A 5- OR 6-MEMBERED HETEROCYCLIC RING, AND HAL IS CHLORINE OR BROMINE, ARE USEFUL FOR THEIR ANTIBACTERIAL EFFECT. THESE COMPOUNDS MAY PRODUCED, INTER ALIA, BY CHORINATING OR BROMINATING A 2-METHYL-O-CARBOXYLIC ACID AMIDO-QUINOXALINE-1,4-DI-NOXIDE OF THE FORMULA: